A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia

This study aimed to examine the effect of venetoclax coupled with azacytidine in treating older adults with relapsed and refractory (R/R) acute myeloid leukemia (AML). The clinical data of 10 senior patients with AML over 65 years old who were treated with venetoclax and azacytidine, including six p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Rong-Hua, Su, Li, Lan, Xiao-Xi, Chang, Xiao-Li, Hui, Wu-Han, Guo, Yi-Xian, Zhao, Hong, Zhang, Yue, Sun, Wan-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Preclinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891270/
https://www.ncbi.nlm.nih.gov/pubmed/36622759
http://dx.doi.org/10.1097/CAD.0000000000001431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9891270/
https://www.ncbi.nlm.nih.gov/pubmed/36622759
http://dx.doi.org/10.1097/CAD.0000000000001431

Ejemplares similares